Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type — Trials · CancerIndex

Clinical trials

Registered studies

125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 2
Growth YoY: —
Industry share: 25%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00901147	Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma	completed	Phase 2	25	Singapore General HospitalOTHER	3	Jun 27, 2014	clinicaltrials
NCT00890747	Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy	completed	Phase 1	42	National Cancer Institute (NCI)NIH	1	Mar 17, 2014	clinicaltrials